Search research articles
Contact Us
Filters
Showing results (1-10 of 79) with videos related to
Page
of 8
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)
|
April 22, 2006
Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for the treatment of metabolic syndrome
Minghan Wang
Handbook of Experimental Pharmacology
|
April 13, 2011
Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy
Minghan Wang
Nutrition & Metabolism
|
February 4, 2005
The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome
Minghan Wang
Mini Reviews in Medicinal Chemistry
|
June 10, 2008
Development of 11beta-HSD1 inhibitors for the treatment of type 2 diabetes
Clarence Hale, Minghan Wang
Journal of Cellular Biochemistry
|
April 12, 2003
Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis
Minghan Wang, Sherrie Tafuri
Chemistry & Biology
|
October 21, 2006
Small-molecule compounds that modulate lipolysis in adipose tissue: targeting strategies and molecular classes
Minghan Wang, Christopher Fotsch
Journal of Inequalities and Applications
|
March 7, 2019
Minimizing Lundberg inequality for ruin probability under correlated risk model by investment and reinsurance
Lin Xu, Minghan Wang, Bin Zhang
Current Topics in Medicinal Chemistry
|
April 23, 2011
Small molecule 11β-hydroxysteroid dehydrogenase type 1 inhibitors
Daqing Sun, Minghan Wang, Zhulun Wang
The Journal of Organic Chemistry
|
November 12, 2025
One-Pot Radical Azidooxygenation of Alkenes Enabled by Dibenzothiophenium Salts
Minghan Wang, Shuhua Liu, Chenglong Zhang, et al.
Current Topics in Medicinal Chemistry
|
December 17, 2008
Inhibitors of 11beta-HSD1: a potential treatment for the metabolic syndrome
David J St Jean, Minghan Wang, Christopher Fotsch
Page
of 8
Search research articles
Search
Showing results (1-10 of 79) with videos related to
Sort By:
Page
of 8
Current Opinion in Investigational Drugs (London, England : 2000)
|
April 22, 2006
Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for the treatment of metabolic syndrome
Minghan Wang
Handbook of Experimental Pharmacology
|
April 13, 2011
Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy
Minghan Wang
Nutrition & Metabolism
|
February 4, 2005
The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome
Minghan Wang
Mini Reviews in Medicinal Chemistry
|
June 10, 2008
Development of 11beta-HSD1 inhibitors for the treatment of type 2 diabetes
Clarence Hale, Minghan Wang
Journal of Cellular Biochemistry
|
April 12, 2003
Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis
Minghan Wang, Sherrie Tafuri
Chemistry & Biology
|
October 21, 2006
Small-molecule compounds that modulate lipolysis in adipose tissue: targeting strategies and molecular classes
Minghan Wang, Christopher Fotsch
Journal of Inequalities and Applications
|
March 7, 2019
Minimizing Lundberg inequality for ruin probability under correlated risk model by investment and reinsurance
Lin Xu, Minghan Wang, Bin Zhang
Current Topics in Medicinal Chemistry
|
April 23, 2011
Small molecule 11β-hydroxysteroid dehydrogenase type 1 inhibitors
Daqing Sun, Minghan Wang, Zhulun Wang
The Journal of Organic Chemistry
|
November 12, 2025
One-Pot Radical Azidooxygenation of Alkenes Enabled by Dibenzothiophenium Salts
Minghan Wang, Shuhua Liu, Chenglong Zhang, et al.
Current Topics in Medicinal Chemistry
|
December 17, 2008
Inhibitors of 11beta-HSD1: a potential treatment for the metabolic syndrome
David J St Jean, Minghan Wang, Christopher Fotsch
Page
of 8